drugset / Trial / NCT00031577

Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

NCT00031577 ↗

Phase 1 Terminated 11 enrolled Children's Hospital of Philadelphia
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Paclitaxel may make the tumor cells more sensitive to radiation therapy. PURPOSE: Phase I trial to study the effectiveness of combining paclitaxel with radiation therapy in treating children who have newly diagnosed brain stem glioma.

Timeline

Start
1999-08
Primary completion
2006-09
Completion
2006-09

Outcome

Outcome not reported

Stopped (Enrollment): “Administrative closure 9/22/2006. Decline in enrollment at CHOP. due to competing protocols with new agents.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule — Intravenous